About 600 reports

  • Hepatitis C
  • Hepatitis B
  • Hepatitis
  • World
  • Market Size
  • QIAGEN N.V.
  • Roche Group
  • HEPATITIS A
  • HEPATITIS A
  • Hepatitis
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Merck & Co., Inc.
  • HEPATITIS
  • HEPATITIS
  • Hepatitis
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Merck & Co., Inc.
  • TREATMENT GUIDELINES FOR HEPATITIS C
  • LEADING TREATMENTS FOR HEPATITIS C, 2016
  • Hepatitis
  • AbbVie Inc.
  • Gilead Sciences, Inc.
  • Janssen Biotech, Inc.
  • Merck & Co., Inc.
  • depicts the treatment patterns of hepatitis C in India. The hepatitis C prevalence
  • depicts the prevalence population of hepatitis C in South Korea. The prevalence
  • Hepatitis
  • Bristol-Myers Squibb Company
  • Gilead Sciences, Inc.
  • Merck & Co., Inc.
  • Roche Group
  • TREATMENT GUIDELINES FOR CHRONIC HEPATITIS B
  • PHASES OF CHRONIC HEPATITIS B INFECTION
  • Hepatitis
  • Demand
  • Gilead Sciences, Inc.
  • Novartis AG
  • Roche Group
  • HEPATITIS C THERAPEUTICS MARKET, GLOBAL, FIRST-IN-CLASS
  • HEPATITIS C THERAPEUTICS MARKET, MAJOR MARKETS,
  • Hepatitis
  • World
  • AbbVie Inc.
  • Gilead Sciences, Inc.
  • Merck & Co., Inc.
  • HEPATITIS C 15 16.48%
  • HEPATITIS B 37 40.66%
  • Hepatitis
  • World
  • Market Size
  • Juno Therapeutics Inc.
  • Merck & Co., Inc.
  • HEPATITIS
  • PREVALENCE DATA OF HEPATITIS C IN EUROPE
  • Hepatitis
  • World
  • Alere Inc.
  • DiaSorin S.p.A.
  • Roche Group
  • HEPATITIS DRUGS INDUSTRY ASSESSMENTS
  • V. HEPATITIS DRUGS MARKET OUTLOOK
  • Hepatitis
  • China
  • Beijing Union Pharmaceutical Co., Ltd.
  • GlaxoSmithKline Tianjin Co., Ltd.
  • Sichuan Medco Pharmaceutical Stock Co., Ltd.
  • Clinical Trial profile. 424 Trial Title
  • Hepatitis C Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Clinical Trial
  • Drug Discovery And Development
  • Hepatitis
  • Pathology
  • World
  • Hepatitis B Immune Globulin
  • Hepatitis B Immune Globulin Exports
  • Hepatitis
  • China
  • Chengdu Ronsen Pharmaceutical Co., Ltd.
  • Hualan Biological Engineering Co., Ltd.
  • Ltd. Hualan Biological Engineering Co., Ltd.
  • Hepatitis B Immune Globulin
  • Hepatitis B Immune Globulin Exports
  • Hepatitis
  • China
  • Chengdu Ronsen Pharmaceutical Co., Ltd.
  • Hualan Biological Engineering Co., Ltd.
  • Ltd. Hualan Biological Engineering Co., Ltd.
  • TREATMENT GUIDELINES FOR CHRONIC HEPATITIS B
  • PHASES OF CHRONIC HEPATITIS B INFECTION
  • Hepatitis
  • China
  • World
  • Arbutus Biopharma Corporation
  • Gilead Sciences, Inc.
  • PHASES OF CHRONIC HEPATITIS B INFECTION
  • TREATMENT GUIDELINES FOR CHRONIC HEPATITIS B
  • Hepatitis
  • World
  • Demand
  • Arbutus Biopharma Corporation
  • Gilead Sciences, Inc.

Hepatitis C

4546 5000 3864
  • TREATMENT: HEPATITIS C
  • Treatment: Hepatitis C
  • Hepatitis
  • Asia
  • Europe
  • Japan
  • World

Hepatitis B Market Forecast ($), Japan, 2015 - 2020 The latest research from Fore Pharma, Global Hepatitis B Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Hepatitis B pipeline products, Hepatitis B epidemiology,

  • Hepatitis
  • France
  • Germany
  • Italy
  • Japan

Hepatitis C Market Forecast ($), Japan, 2015 - 2020 The latest research from Fore Pharma, Global Hepatitis C Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Hepatitis C pipeline products, Hepatitis C epidemiology,

  • Hepatitis
  • France
  • Germany
  • Italy
  • Japan

Executive Summary: Global Hepatitis E Diagnostic Tests Market ##.

  • Hepatitis
  • Pathology
  • World
  • Forecast
  • Management of Hepatitis B Infection
  • Hepatitis B Disease Classification
  • Hepatitis
  • Therapy
  • World
  • Gilead Sciences, Inc.
  • Tekmira Pharmaceuticals Corporation
  • Market size and forecast
  • Proportions of HBV and HCV-related HCC in APAC
  • Hepatitis
  • World
  • Forecast
  • Eli Lilly & Co.
  • Pfizer Inc.

Key Features of the Report: - Hepatitis B: Disease Definition - Hepatitis B Patient Flow - Hepatitis B Prevalence - Hepatitis B Diagnosed Patients - Hepatitis B Treated Patients

  • Hepatitis
  • Pathology
  • Europe
  • World
  • Forecast

Global Hepatitis Drug Clinical Pipeline Overview ##. ## Hepatitis A ##. ## Hepatitis B ##. ## Hepatitis C ##. ## Hepatitis D ##. ## Hepatitis E ##.

  • Hepatitis
  • Pathology
  • World
  • Forecast
  • HEPATITIS C VIRUS GENOTYPE DESCRIPTION
  • 3.1 BIBLIOGRAPHY
  • Hepatitis
  • Brazil
  • China
  • United Kingdom
  • Forecast
  • Other Hepatitis Drugs
  • Hepatitis Drugs Imports
  • Hepatitis
  • China
  • Beijing Union Pharmaceutical Co., Ltd.
  • GlaxoSmithKline Tianjin Co., Ltd.
  • Sichuan Medco Pharmaceutical Stock Co., Ltd.
  • Other Hepatitis Drugs
  • Hepatitis Drugs Companies in China
  • Hepatitis
  • China
  • Beijing Union Pharmaceutical Co., Ltd.
  • GlaxoSmithKline Tianjin Co., Ltd.
  • Livzon Group
  • GLOBAL HEPATITIS THERAPEUTICS MARKET
  • GLOBAL HEPATITIS THERAPEUTICS MARKET 2016-2021 ($ BILLIONS)
  • Hepatitis
  • World
  • Bristol-Myers Squibb Company
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • LIST OF ABBREVIATIONS
  • NAATS FOR BLOOD SCREENING
  • Hepatitis
  • World
  • bioMerieux S.A.
  • Grifols, S.A.
  • Roche Group
  • MM, SOURCES USED FOR HEPATITIS C CO-INFECTION
  • and Figure 1 show the diagnosed prevalent cases of chronic hepatitis B in the 8MM...
  • Hepatitis
  • China
  • Japan
  • United States
  • Forecast

Most cases of HCC result either from infection with viral hepatitis (Hepatitis B or C), metabolic toxins such as alcohol or aflatoxin, conditions such as hemochromatosis and alpha-deficiency ##-antitrypsin, or NASH.

  • Hepatitis
  • Pathology
  • World